Analyze Molecular and Clinical Effects of CCR4 Antagonist RPT193 on Patients with AD
The following is a summary of "Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study," published in the November 2023 issue of Allergy & Immunology by Bissonnette, et al. RPT193 is a small-molecule antagonist of the...